Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,100
Closed -$251K 5155
2025
Q1
$251K Buy
+2,100
New +$260K ﹤0.01% 3860

Other funds holding XYL

Squarepoint's XYL Position: Q2 2026 in Review

Squarepoint reduced its Xylem (XYL) stake by 56% in Q2 2026, selling an estimated $8.1M and leaving 55,313 shares worth $6.54M. The position accounts for 0.01% of the portfolio, ranked #1378.

Squarepoint first reported a position in XYL in Q4 2015 and has held it in 31 quarters since. The position peaked at $51.8M in Q2 2023. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Squarepoint held 55,313 shares of Xylem worth $6.54M as of Q2 2026.
  • Squarepoint sold 70,140 Xylem shares in Q2 2026, an estimated $8.1M.
  • Xylem made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1378 holding.
  • Squarepoint first reported a position in Xylem in Q4 2015 and has held it in 31 quarters since.
  • Squarepoint's Xylem position peaked at $51.8M in Q2 2023.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.